Tarsus Pharmaceuticals, Inc. short interest in 2023
In 2023, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 3.89% of shares outstanding on 13 Jan 2023 to 15.11% on 29 Dec 2023, a change of +11.22 percentage points. The year's high was 15.22% on 29 Sep 2023 and its low 3.19% on 15 May 2023, averaging 8.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.35 days on 14 Jul 2023. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 3.89% (13 Jan 2023)
- End of year
- 15.11% (29 Dec 2023)
- Change
- +11.22 pp
- High
- 15.22% (29 Sep 2023)
- Low
- 3.19% (15 May 2023)
- Average
- 8.82%
- Highest days to cover
- 27.35 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 3.89% | 13.85 | |
| 31 Jan 2023 | 3.63% | 8.18 | |
| 15 Feb 2023 | 3.70% | 24.74 | |
| 28 Feb 2023 | 3.74% | 17.16 | |
| 15 Mar 2023 | 3.90% | 17.28 | results (8-K) |
| 31 Mar 2023 | 3.71% | 11.35 | 10-K filed |
| 14 Apr 2023 | 3.59% | 6.81 | |
| 28 Apr 2023 | 3.59% | 3.55 | |
| 15 May 2023 | 3.19% | 6.92 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.40% | 4.84 | |
| 15 Jun 2023 | 5.89% | 6.44 | |
| 30 Jun 2023 | 8.37% | 7.61 | |
| 14 Jul 2023 | 8.56% | 27.35 | |
| 31 Jul 2023 | 14.20% | 4.67 | |
| 15 Aug 2023 | 13.73% | 6.36 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 13.82% | 18.48 | |
| 15 Sep 2023 | 13.47% | 9.61 | |
| 29 Sep 2023 | 15.22% | 13.89 | |
| 13 Oct 2023 | 12.26% | 7.14 | |
| 31 Oct 2023 | 12.87% | 9.99 | |
| 15 Nov 2023 | 13.47% | 6.14 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 13.45% | 7.14 | |
| 15 Dec 2023 | 14.83% | 7.64 | |
| 29 Dec 2023 | 15.11% | 6.85 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.